A Question of Chimeras :The Scientist [11/4/2005]

Supplements

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

Institutions

For Advertisers

by Clare Kittredge

BIOBUSINESS

A Question of Chimeras

Scientists say ruling on protest patent won't have an impact on future chimeric-animal patents

Email: Clare Kittredge - ckittredge@the-scientist.com
The Scientist 2005, 19(7):54

Published

11 April 2005

Looking to cure a host of neurodegenerative diseases, StemCells, a Palo Alto, Calif.-based company, has transplanted human neural stem cells into the brains of thousands of mice. The mice are technically chimeras, or is a mix of two or more species. (The word "chimera" refers to the Greek mythological creature that has a lion's head, a goat's body, and a serpent's tail.) President and CEO Martin McGlynn says his biotech company is now waiting for the FDA's permission to test human neural stem cells – the ones already tested in mice – in human patients.


	The article you are attempting to read is Premium content which is only available to our online subscribers.

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today